Mesothelioma Trial, Recruiting NCT05655078 Sponsor: University College, London Condition: Mesothelioma
Back to Mesothelioma

Mesothelioma Trial, Recruiting

NCT05655078
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are 18 years of age or older and have been diagnosed with malignant pleural mesothelioma (a type of cancer affecting the lining of the lungs), confirmed by a tissue biopsy that also identified the specific type
  • Your cancer has not spread to distant parts of the body, and lymph node involvement is limited or absent
  • You and your medical team have agreed to monitor the cancer closely for now, rather than starting drug treatment straight away
  • You are in good general health and able to carry out everyday activities with no more than minor limitations (confirm with trial site)
  • Your cancer is only affecting one side of the chest, based on a CT scan
  • Your lungs are working well enough to meet specific breathing test thresholds (confirm with trial site)
  • You are willing and able to travel to one of two specialist radiotherapy centres (UCLH in London or The Christie in Manchester) if assigned to the treatment group
  • You are willing to attend follow-up appointments at a local trial site
  • Your medical team believes you are likely to be able to complete the radiotherapy planning process

Who may not be able to join:

  • Your cancer has spread to other parts of the body or to the other side of the chest
  • Your diagnosis was based only on fluid analysis rather than a tissue biopsy, or the cancer type has not been clearly identified
  • You have previously had radiotherapy, chemotherapy, or immunotherapy for this cancer
  • You have previously had major surgery to remove the affected lung lining or lung for this cancer
  • You and your medical team feel that drug treatment or surgery needs to start immediately, rather than taking a watch-and-wait approach
  • Your cancer has spread to lymph nodes on the other side of the chest or in the neck area
  • Your cancer has grown into the heart muscle
  • Your cancer has spread to lymph nodes further afield or to distant parts of the body
  • You have a new fluid build-up around the lung that cannot be drained
  • Your general health and ability to carry out daily activities are significantly limited
  • You are currently pregnant or breastfeeding
  • You have or have had another cancer that may affect your life expectancy
  • You have a pacemaker or an implanted heart device called a cardioverter-defibrillator
  • You have a significant lung scarring condition (mild or incidental findings may be acceptable — confirm with trial site)
  • You have a serious non-cancer health condition where your estimated chance of surviving three years is less than 20%
  • You have previously had radiotherapy to the chest or abdomen for a cancer and this was not discussed with the trial organisers before you were considered for the study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Crispin Hiley, University College, London

Phone: 020 7679 9826

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
28 March 2024
Est. completion
31 March 2029

Where this trial is recruiting

🇬🇧 United Kingdom

Primary endpoints

Progression free survival; Overall survival

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov